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Although Alzheimer’s disease presents homogeneous histopathology, it causes several
clinical phenotypes depending on brain regions involved. Beside the most abundant
memory variant, several atypical variants exist. Among them posterior cortical atrophy
(PCA) is associated with severe visuospatial/visuoperceptual deficits in the absence of
significant primary ocular disease. Here, we report for the first time a case of Capgras
delusion—a delusional misidentification syndrome, where patients think that familiar
persons are replaced by identical “doubles” or an impostor—in a patient with PCA. The
57-year-old female patient was diagnosed with PCA and developed Capgras delusion
8 years after first symptoms. The patient did not recognize her husband, misidentified
him as a stranger, and perceived him as a threat. Such misidentifications did not happen
for other persons. Events could be interrupted by reassuring the husband’s identity by
the patient’s female friend or children. We applied in-depth multimodal neuroimaging
phenotyping and used single-subject voxel-based morphometry to identify atrophy
changes specifically related to the development of the Capgras delusion. The latter,
based on structural T1 magnetic resonance imaging, revealed progressive gray matter
volume decline in occipital and temporoparietal areas, involving more the right than
the left hemisphere, especially at the beginning. Correspondingly, the right fusiform
gyrus was already affected by atrophy at baseline, whereas the left fusiform gyrus
became involved in the further disease course. At baseline, glucose hypometabolism
as measured by positron emission tomography (PET) with F18-fluorodesoxyglucose
(FDG-PET) was evident in the parietooccipital cortex, more pronounced right-sided,
and in the right frontotemporal cortex. Amyloid accumulation as assessed by PET with
F18-florbetaben was found in the gray matter of the neocortex indicating underlying
Alzheimer’s disease. Appearance of the Capgras delusion was related to atrophy in the
right posterior cingulate gyrus/precuneus, as well as right middle frontal gyrus/frontal
eye field, supporting right frontal areas as particularly relevant for Capgras delusion.
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Atrophy in these regions respectively might affect the default mode and dorsal attention
networks as shown by meta-analytical co-activation and resting state functional
connectivity analyses. This case elucidates the brain-behavior relationship in PCA and
Capgras delusion.
Keywords: Balint’s syndrome, Capgras delusion, delusional misidentification syndrome, MRI, posterior cortical
atrophy
BACKGROUND
Alzheimer’s disease constitutes a major public health problem.
Whereas its histopathology is rather homogeneous with amyloid
and tau accumulation in the brain, it causes several clinical
phenotypes (Warren et al., 2012). Clinically, the most frequent
related dementia syndrome, typical Alzheimer’s dementia, is
characterized by memory dysfunction (Dubois et al., 2007,
2014; McKhann et al., 2011). Beside the memory variant
several atypical variants exist. Among them posterior cortical
atrophy (PCA) is associated with severe visuospatial and
visuoperceptual deficits in the absence of significant primary
ocular disease (Warren et al., 2012; Crutch et al., 2017).
Further PCA symptoms include simultanagnosia with or without
optic ataxia or ocular apraxia, constructional dyspraxia, visual
field defects, environmental disorientation, and Gerstmann’s
syndrome. Remarkably, PCA is frequently diagnosed late
in the course of the disease as the syndrome does not
show apparent primary ocular disease giving easy explanation
of problems and is a rare orphan disease, unfamiliar to
most physicians.
Recently, delusional misidentification syndromes have been
described in dementia syndromes, in particular in Alzheimer’s
disease, dementia with Lewy bodies, and semantic dementia
(Cipriani et al., 2013). These syndromes are psychopathologic
phenomena, where patients consistently misidentify persons,
places, objects, or events. In the Capgras delusion or syndrome
of doubles, persons think that familiar persons are replaced
by identical doubles or an impostor. Of note, there are
no significant changes in the physical appearance of the
misidentified objects. This syndrome was firstly described
in 1923 by Capgras and Reboul-Lachaux, who coined it
illusion de sosies. Capgras delusion is most often related to
the spouse and siblings, i.e., people with whom the patient
has strong emotional bonds and associative memories,
where the double is assumed to have evil intent (Cipriani
et al., 2013). Capgras delusion has been initially described
in psychiatric diseases such as paranoid schizophrenia and
schizoaffective disorder, later on in neurological diseases
such as cerebrovascular disease, epilepsy, head injury, and
dementia syndromes. Recent studies identified right frontal
areas (Cipriani et al., 2013; Fiacconi et al., 2014; Darby and
Prasad, 2016; Darby et al., 2017), right temporal/occipital
cortex (Halligan and David, 2001; Metin et al., 2019),
and retrosplenial cortex (Darby et al., 2017) as relevant
for Capgras delusion. Here, we report the first case of
Capgras delusion in a patient with PCA and identify its
neural correlates.
CASE PRESENTATION
The 57-year-old female patient presented together with her
spouse to the Clinic for Cognitive Neurology at the University
Hospital Leipzig, Germany, with visual impairment that had
developed gradually over the last 3 years. The patient worked
as a secretary. There, she recognized problems writing with ten
fingers on the computer keyboard, using computer programs,
organizing dates. Moreover, she and her husband described
problems in everyday life, in particular losing the ability to
identify correct time on watches, keep lines when reading and
writing, open the door with a key, put a plug to a socket, switch
on/off the kitchen stove and other kitchen equipment, put cutlery
into the drawer, load the dishwasher, put shoes or clothing into
cupboards, dressing, and word finding difficulties. The patient
described visuospatial and visuoperceptual problems as “things
don’t fit to each other,” “I cannot find any order.” Remarkably,
three ophthalmologic investigations could not identify any
specific related pathology, but recommended using glasses. One
year before admission, a burn-out syndrome was diagnosed and
the antidepressive drug venlafaxine administered.
Investigations
Investigations with structural magnetic resonance imaging (MRI)
2 and 1 year before admission and visual evoked potentials (VEP)
did not reveal any pathological findings. A lumbar puncture
revealed reduced amyloid-beta 1–42 levels and normal values
for total and phospho tau as well as negative protein 14-3-3 in
cerebrospinal fluid (CSF).
Baseline Investigation
Figure 1 illustrates brain imaging findings. A structural
MRI revealed brain atrophy especially in parietooccipital
regions and, accordingly, enlargement of posterior ventricles.
Single small white matter lesions did not reach pathologically
relevant extent. Positron emission tomography (PET) with
F18-fluorodesoxyglucose (FDG-PET) as a neuronal injury
marker revealed glucose hypometabolism bilaterally in
parietooccipital cortex, more pronounced on the right side, and
in the right frontotemporal cortex. PET with F18-florbetaben
showed amyloid accumulation in the gray matter of the neocortex
(posterior cingulate, parietooccipital, and frontal cortex).
Clinical in-depth phenotyping revealed severe Balint’s
syndrome with simultanagnosia, optic ataxia, ocular apraxia and
visuospatial/visuoperceptual deficits, incomplete homonymous
anopsia in the left lower quadrant, hemineglect on the left side,
form and object agnosia. Although the patient did not recognize
therapists in clinical routine that might indicate prosopagnosia,
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FIGURE 1 | Multimodal imaging findings in a patient with posterior cortical atrophy at baseline and follow-up investigations. (Left) Positron emission tomography
(PET) with F18-fluorodesoxyglucose (FDG-PET) reveals decreases in glucose metabolism: upper row in the patient (SUV standardized uptake value), second row
compared to a healthy control cohort using NEUROSTAT/3D-SSP software (https://neurostat.neuro.utah.edu). Bottom rows show amyloid-beta accumulation in
patient’s individual F18-florbetaben PET scan compared to a healthy control cohort using Hermes BRASS software (Hermes Medical Solution, Stockholm, Sweden).
(Right) Structural magnetic resonance imaging (MRI), T1 sequence, illustrating atrophy. Note that Capgras delusion was firstly evident between third and fourth
follow-up. L, left; R, right.
face recognition was possible, but with a reduced speed, in a facial
recognition test for unknown faces. Deficits led to an impairment
of exploration and reading abilities with problems in orientation
in traffic, rooms, and on pages. Related clinical symptoms
included alexia, agraphia, acalculia, deficits in attention, and with
a lesser extent in memory and executive functions. The patient
reached 24 out of 30 possible points in the Mini Mental State
Examination (MMSE) 2 months before baseline investigation,
and then she scored 23 points. The patient did not show any
hints for proper aphasia. The patient was impaired in everyday
life activities. Supplementary Video S1 illustrates clinical
symptoms including simultanagnosia during visual exploration
and object agnosia in clinical examination, optic ataxia combined
with visuospatial and visuoperceptual deficits with problems in
placing a plate into the dishwasher, putting a plug to a socket, and
using a water boiler, and finally tactile compensation of deficits.
Although the patient had problems in recognizing a fork or
spoon visually (see third movie part for object agnosia), she could
easily identify these items based on tactile information without
visual information (eyes had been covered by blindfold, see last
movie part for tactile compensation). Interestingly, this strategy
was also applied successfully by the patient spontaneously when
she failed in her first attempt with putting a plug to a socket (see
second movie part for optic ataxia).
Differential Diagnosis
Differential diagnosis of neurodegenerative diseases has
to take clinical syndromes and biomarkers from imaging
and CSF as surrogate indicators for histopathology into
account as recently suggested in clinical diagnostic criteria
(Schroeter et al., 2009; McKhann et al., 2011; Schroeter and
Neumann, 2011). In accordance with this conceptual shift,
Crutch et al. (2017) suggested a three-level classification
framework for PCA comprising both syndrome and disease-level
descriptions. On classification level 1 the patient fulfilled the
core features of the PCA clinico-radiological syndrome, i.e.,
clinical criteria with insidious onset, gradual progression,
prominent early disturbance of visual and/or other posterior
cognitive functions, and the cognitive features with space
perception deficit, simultanagnosia, object perception deficit,
constructional dyspraxia, environmental agnosia, oculomotor
apraxia, dressing apraxia, optic ataxia, alexia, acalculia, agraphia,
and homonymous visual field defect. Later on (see below),
further discussed PCA features, apperceptive prosopagnosia,
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finger agnosia, and left/right disorientation were also fulfilled
(Gerstmann’s syndrome). Neuroimaging indicated predominant
occipitoparietal or occipitotemporal atrophy on MRI and
parietooccipital hypometabolism on FDG-PET. Classification
level 2 revealed pure PCA without fulfilling core clinical criteria
for any other neurodegenerative syndrome. Classification level
3 provided biomarker-evidence for Alzheimer’s disease as
the underlying pathology in accordance with the suggested
criteria for this disease, i.e., decreased amyloid beta 1–42 in CSF
and neocortical amyloid-beta accumulation in PET (Dubois
et al., 2007, 2014). There was no evidence for familial/genetic
etiology and no autopsy information available. As suggested in
McKhann et al. (2011) there was evidence for both Alzheimer’s
disease etiology (amyloid alterations as shown in PET and CSF)
and neuronal injury (FDG-PET, structural MRI; for imaging
meta-analyses see Schroeter and Neumann, 2011, and Schroeter
et al., 2009). In sum, the patient suffered from PCA on a
syndrome-clinical level with evidence for underlying Alzheimer’s
disease on imaging and biomarker levels.
Treatment
An acetylcholine-esterase-inhibitor (galantamine) starting
with a daily dose of 8 mg was administered due to underlying
Alzheimer’s disease. Deficits were treated in a day clinic
out-patient setting with a multimodal approach including
orthoptists, occupational therapists, neuropsychologists,
patholinguists, and physiotherapists. Support by occupational
therapy, patholinguistic therapy, and psychotherapy was
recommended to be continued after discharge.
Outcome
First Follow-Up Investigation
Eight months later the patient was re-examined. Dosage of
galantamine was increased to 24 mg daily in the meantime.
Intensive therapy by orthoptist and patholinguist improved
reading of words and sentences, whereas reading of numbers
and writing of words and sentences did show more mistakes.
These changes were related to a decline in visuospatial
and visuoperceptual functions, the left-sided hemineglect, and
simultanagnosia. Whereas at first investigation the patient could
perceive three objects simultaneously, at follow-up only two
objects were detected. The patient was functionally blind and had
to rely on support by her spouse. Prosopagnosia was detected
in facial recognition test and prosopagnosia test. MMSE score
reached now 22 out of 30 possible points.
Second Follow-Up Investigation
During the follow-up 17 months later, the patient reported
further deterioration of visuospatial and visuoperceptual abilities
including reading and writing, whereas she could better
compensate deficits by putting things into cupboards by using
strategies. She also told that she identified persons now by
their voice and/or gait instead of recognizing their face. She
reported failing sitting on chairs by sitting beside it. The husband
reported depressive mood. Coxarthrosis required implantation of
endoprostheses in both hip joints. In the meantime, dosage of
galantamine was reduced to 16 mg daily due to nausea as a side
effect. Investigations revealed additionally finger agnosia, deficits
in body schema, and temporal orientation. The neuropsychiatric
inventory excluded changes in personality/behavior besides
slightly depressive mood. As illustrated in Figure 1 structural
MRI indicated regional atrophy with slight increase in extent
but without qualitative changes. Semantic abilities were now
slightly impaired. Symptoms of the Balint’s syndrome, especially
simultanagnosia, and cognitive abilities showed further decline
if compared with earlier investigations (patient could perceive
only one object now at one time, MMSE score 18 out of
30 points). These higher deficits led to misinterpretations of
everyday usage objects, persons, and stronger impairments in
everyday activities. Occupational therapy was now recommended
in the patient’s household.
Third Follow-Up Investigation
At follow-up 17 months later, the patient and spouse reported
further deterioration in higher order visual processing. According
to the spouse the patient once had the illusion of people
sitting in the garden, which were actually not there. This never
happened again. Furthermore, the patient suspected that her
husband would be interested in other women. Structural MRI
revealed again severe cortical and subcortical atrophy, now with
temporomesial atrophy (medial temporal lobe atrophy according
to Scheltens’ 2 left/3 right; at baseline and at second follow-up
1 left/2 right). Thorough neuropsychological testing was not
possible anymore due to deficits’ severity.
Fourth Follow-Up Investigation
The patient and spouse visited the clinic 14 months later. They
reported further general decline of visuospatial/visuoperceptual
abilities deteriorating everyday life activities. She could not use a
knife and fork during eating appropriately. The husband added
that the patient used her left hand less. Symptoms suspicious
for hallucinations or paranoia were not reported any more.
Most remarkably, the husband now stated that the patient
sometimes did not recognize him and misidentified him rather
as a stranger (Supplementary Video S2 taken by spouse). During
these episodes she also perceived him as a threat; once or two
times she even told that she had been raped. These events
occurred now daily with a duration of 1 h. Such misidentifications
would not happen for other persons. To interrupt such events by
re-identifying the spouse as her husband he would have to call
their children or the patient’s female friend by phone, to calm
her and reassure her regarding the husband’s identity. Structural
MRI (Figure 1) revealed more widespread atrophy compared
with the previous MRIs, especially in temporoparietooccipital
areas. Temporomesial atrophy reached now stage 3 bilaterally on
the Scheltens’ scale. In the meantime, the frontal cortex was also
involved. Ventricles were largely extended especially in posterior
and temporal regions. Neuropsychological investigations, only
possible for rough tests, showed further cognitive decline with
now 4 out of 30 possible points in the MMSE. Visuospatial
and visuoperceptual abilities, the Balint’s syndrome, and left-
sided hemineglect were further deteriorated. Although low vision
could be compensated by tactile information during previous
examinations, this compensatory strategy was not applicable any
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more. Orientation was even impaired in their own flat. To cope
with misidentification events the antipsychotic quetiapine and
behavioral interventions were recommended beside respite care,
occupational therapy at home, and support by assistants.
Single-Subject Voxel-Based
Morphometry
To validate the impact of structural imaging changes on
the disease course and, in particular, the development of
Capgras delusion quantitatively, we performed a single-subject
voxel-based morphometry (VBM) analysis using MRI data. Here,
progress of brain atrophy was quantitatively analyzed over time in
the case-subject by comparing each timepoint of MRI scans to a
healthy elderly cohort.
Method
Voxel-based morphometry identified differences that are specific
for each timepoint in the patient’s disease course compared
to a healthy control cohort. Here, 42 healthy controls (mean
age ± SD = 69.6 ± 6.6 years) were contrasted to the four
MRI measurements of the patient (baseline, age = 57.8; second
follow-up, age = 60.0; third follow-up, age = 61.2; fourth
follow-up, age = 62.4 years) in four separate analyses.
Voxel-based morphometry was performed applying the
CAT12 toolbox (University of Jena, Germany) with SPM12
(University College London, United Kingdom). Images were
spatially normalized, segmented, modulated by the amount
of linear and non-linear deformations, and smoothed with
a Gaussian kernel of 8-mm full-width at half-maximum.
Voxel-wise Student’s t-tests were performed to compare each
timepoint of the patient with controls. Nuisance covariates were
used to control for differences in age and total intracranial
volume. Significant clusters were detected using an uncorrected
voxel-threshold of p < 0.005 and a family-wise error (FWE)
corrected cluster-threshold of p < 0.05. To visualize the disease
progression, resulting gray matter volume (GMV) maps from the
single timepoints comparisons were binarized and superimposed
to create an overlay analysis.
As aforementioned, the Capgras delusions emerged between
the last two visits. Accordingly, we regarded atrophy changes
between the third and fourth follow-ups as the most informative,
as they are timely coincident with the emergence of the symptoms
of interest. In order to graphically display the trend over time
in GMV reductions, we performed an additional data-driven
region-of-interest (ROI) analysis. Using marsbar v.0.441, we
extracted the average GMV values from data-driven ROIs
defined according to the atrophy pattern characteristic of the
case-patient during the fourth follow-up. Namely, we created
three ROIs, one encompassing the overall PCA pattern (i.e.,
including extensively occipital and temporoparietal cortex) and
two from the brain regions that emerged concurrently with the
Capgras delusion in the transition between the third and fourth
follow-up, i.e., posterior cingulate gyrus/precuneus and middle
frontal gyrus/frontal eye field (respectively, centered on the MNI
x, y, z coordinate 4, −32, 44 and 28, 0, 51). GMV values for
1http://marsbar.sourceforge.net
the healthy controls were summarized in a boxplot and values
for each timepoint for the patient are visualized separately. In
addition, we also extracted the total GMV of the patient at each
timepoint to measure overall atrophy changes.
Results
As illustrated in Figure 2 and Supplementary Video S3 the
single-subject VBM analysis revealed general progressive GMV
decline in occipital and temporoparietal areas from baseline
to fourth follow-up. Generally, atrophy involved more the
right than the left hemisphere, especially in the beginning of
imaging investigations. Atrophy was already observed in the
right fusiform gyrus at baseline, whereas the left fusiform
gyrus appeared relatively spared at baseline but was severely
compromised at fourth follow-up. Most specific changes during
transition from the third to the fourth follow-up, i.e., the
appearance of the Capgras delusion, are illustrated in yellow
color in the left bottom panel in Figure 2 and in Supplementary
Video S3. New GMV reduction was found at this timepoint
in the posterior cingulate gyrus/precuneus, as well as in the
right middle frontal gyrus/frontal eye field. The ROI analyses
revealed that summarized GMV values in the healthy control
group were always higher in all of the three investigated regions.
GMV values declined with each follow-up in all of the three
ROIs (Figure 2, right panel). Of note, no sharp decline in GMV
was detected in any of the three ROIs, rather a slow, progressive
decrease. A similar decrease rate was also evident in the overall
progression of atrophy as quantified by a gradual loss of total
GMV from baseline to the last follow-up (468 cm3 450 cm3
417 cm3 403 cm3).
Extracting Functionally Impaired Brain
Networks by Connectivity Analyses
Method
To further explore the significance of atrophy differences between
the third and the fourth follow-up for functionally associated
brain networks, we applied two additional analytical techniques
via Neurosynth2 (Yarkoni et al., 2011; see also Schroeter et al.,
2020): (1) meta-analytic co-activation modeling (MACM), which
identifies co-activation of brain regions across studies reported
in the Neurosynth database (N = 14,371 as of March 2020); and
(2) seed-based resting state functional connectivity based on a
sample of 1,000 healthy controls (Choi et al., 2012). The seeds
for both analyses were created as 6 mm radius spheres centered
in the atrophy maxima of the two clusters that differentiated the
patients and controls at the fourth follow-up but not at previous
timepoints, i.e., in the posterior cingulate/precuneus and in the
frontal gyrus/frontal eye fields (coordinates in MNI space 4,−32,
44, and 28, 0, 52).
Results
Results from both MACM and seed-based resting-state
functional connectivity were highly consistent for each seed
(Figure 3). The seed in the right frontal gyrus/frontal eye field
showed preferential co-activations and functional connectivity
2http://www.neurosynth.org
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FIGURE 2 | Quantifying dynamic structural imaging changes in single-subject voxel-based morphometry analysis. (Left) Top panel displays results of the voxel-based
morphometry analysis showing, at each timepoint, the impairment in gray matter volume (GMV) in the patient compared to a normative elderly healthy control group.
Bottom panel shows overlay of patient’s atrophy across the four timepoints, clearly displaying disease progression over time. The same results are presented in
Supplementary Video S3. (Right) Results of the regions-of-interest (ROI) analysis illustrating atrophy progression (GMV decline). The upper graph is related to the
progression of the disease in the overall disease-specific pattern, i.e., regions affected at fourth follow-up. The middle and the bottom graphs show GMV changes in
the clusters timely associated with the emergence of Capgras delusion, i.e., right posterior cingulate gyrus/precuneus, and middle frontal gyrus/frontal eye field
(respectively, centered at MNI coordinates x, y, z 4, –32, 44 and 28, 0, 51). Significant results are shown at p < 0.05 family-wise error corrected (FWE) at cluster level
(cluster forming threshold p < 0.005). Images are displayed in radiological convention: left of the figure displayed on the right of the image.
with its contralateral homolog, and with the bilateral superior
parietal cortex, closely resembling the architecture of the dorsal
attention network. The seed in the posterior cingulum/precuneus
showed to be functionally connected/co-activated with the
bilateral inferior parietal cortex and medial frontal and anterior
cingulate cortex, well-known components of the default mode
network. The two brain networks connected/co-activated with
the seeds were topographically dissociated.
DISCUSSION
Here, we report, to the best of our knowledge, the first
case of Capgras delusion in a patient with PCA. PCA was
diagnosed in this female patient 3 years after beginning of
clinical disturbances starting at 54 years of age. Clinical in-depth
phenotyping and investigations with multimodal imaging and
biomarkers from CSF revealed pure PCA fulfilling diagnostic
criteria in the three-level classification framework for PCA as
suggested by Crutch et al. (2017) comprising both syndrome- and
disease-level descriptions. Beside the full clinical syndrome, the
patient showed typical findings in neuroimaging with MRI and
FDG-PET. Amyloid-beta PET and amyloid-beta in CSF provided
biomarker-evidence for Alzheimer’s disease as the underlying
pathology (Dubois et al., 2007, 2014; Warren et al., 2012).
Most importantly, approximately 5 years after first diagnosis
of PCA and subsequent stepwise decline in higher order
visual processing and cognitive abilities, the patient developed
a delusional misidentification syndrome—Capgras delusion—
which has never been described in the literature in PCA before.
Harciarek and Kertesz (2008) investigated the prevalence of
delusional misidentification syndromes in a large cohort with
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FIGURE 3 | Extracting functionally impaired brain networks by mapping atrophy to resting-state networks and functional co-activations. (Top) Graphical
representation of the clusters of brain atrophy timely associated with the emergence of Capgras delusion, i.e., right posterior cingulate gyrus/precuneus, and middle
frontal gyrus/frontal eye field. Coordinates of the maxima for each of the two clusters are reported in MNI space in the figure: x, y, z 4, –32, 44, and 28, 0, 52.
(Middle) Results of the meta-analytic co-activation modeling (MACM) across >14,000 fMRI studies from the Neurosynth database (https://neurosynth.org/). Red
blobs represent z-scores after correction for false discovery rate (FDR). (Bottom) Results of the seed-based resting-state functional connectivity analysis on an
independent sample of N = 1,000 healthy controls generated with Neurosynth. Red blobs show Pearson’s correlations with the seed, thresholded at r ≥ 0.2,
uncorrected. Images are displayed in radiological convention. Left of the figure displayed on the right of the image.
neurodegenerative diseases. Generally relatively high prevalence
was observed in Alzheimer’s disease (15.8%) and dementia
with Lewy bodies (16.6%), lower values in semantic dementia
(8.3%). A recent case study also reported Capgras delusion
in a patient with anterior left temporal lobe atrophy showing
clinically symptoms of semantic dementia and behavioral variant
frontotemporal dementia (Metin et al., 2019).
Capgras delusion is relatively common in Alzheimer’s
disease (Cipriani et al., 2013). Surrogate biomarkers for
histopathology revealed Alzheimer’s disease in our patient as
well. However, the patient never showed hints for typical
Alzheimer’s dementia with prominent memory impairment
or Lewy body dementia beside one appearing non-recurring
visual hallucination. Capgras delusion appeared in our patient
with an age of 62 years, earlier than described in Alzheimer’s
disease with a mean age of 72 to 73 years (Cipriani et al.,
2013). Because in our patient Capgras delusion developed
in the course of the disease 8 years after clinical onset of
PCA, one might assume that (histopathologically) underlying
Alzheimer’s disease might also be the cause for this syndrome in
our patient.
Cipriani et al. (2013) discuss that patients with Capgras
delusion are characterized by unilateral brain lesions in the
right hemisphere, in particular frontal areas (see also Darby and
Prasad, 2016), and that underactivity in the perirhinal cortex
seems to lead to loss of familiarity in this syndrome. Fiacconi
et al. (2014) showed that medial prefrontal cortex atrophy was
associated with Capgras delusion in dementia with Lewy bodies.
Other authors (Halligan and David, 2001) suggest that Capgras
delusion is related to alterations in information processing in
the right temporal/occipital cortex. They propose that delusion
arises from a deficit in face processing, where information
about a subject’s facial identity is processed in brain regions
disconnected from relevant affective information regarding the
full identity of the face’s owner. The delusion would occur if the
patient aims at explaining or reconciling the subject’s identity
without having its affective information. Note that delusional
misidentification syndromes have also been observed in semantic
dementia (Harciarek and Kertesz, 2008) well known to be related
to anterior temporal hypometabolism and atrophy (Schroeter
et al., 2007; Bisenius et al., 2016, 2017). Capgras delusion
has also been reported in a patient with anterior temporal
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atrophy showing symptoms of behavioral variant frontotemporal
dementia besides that of semantic dementia (Metin et al., 2019).
Imaging findings in our patients support these assumptions
(see Figure 1). FDG-PET, as a neuronal injury marker,
revealed glucose hypometabolism in the right frontotemporal
cortex, and parietooccipital cortex (the latter known for PCA;
Warren et al., 2012) more pronounced right-sided, already
at baseline. As illustrated in Figure 1, atrophy as measured
with structural MRI spread during the course of the disease,
involving at last follow-up investigation also frontal areas
beside occipitoparietotemporal areas including the fusiform
gyrus/parahippocampal and perirhinal cortex pronounced on the
right side, where early atrophy mainly in occipitoparietal areas is
described in PCA (Warren et al., 2012; Firth et al., 2019).
The in-depth single-subject VBM analysis based on structural
MRI quantified the atrophy changes across the disease course
(Figure 2). It showed general progressive GMV decline in
occipital and temporoparietal areas, remarkably involving more
the right than the left hemisphere, especially at the beginning.
Correspondingly, the right fusiform gyrus was already affected
by atrophy at baseline, whereas the left fusiform gyrus became
involved in the further disease course. Most remarkably, the
transition analysis from the third to the fourth follow-up
revealed new brain atrophy in the right posterior cingulate
gyrus/precuneus, as well as in the right middle frontal
gyrus/frontal eye field functionally connected to the default
mode and dorsal attention networks that might have led
to the development of the Capgras delusion in this patient.
This single-subject VBM analysis elucidates the brain-behavior
relationship in Capgras delusion in PCA and extracts these brain
regions as particularly relevant for Capgras delusion. Note that
our results agree also with histopathological studies reporting
neurofibrillary tangles in occipital lobe, temporoparietal junction,
and posterior cingulate in PCA, whereas amyloid plaques are
more variable (Warren et al., 2012).
Our results confirm right frontal areas as relevant for Capgras
delusion as suggested by Cipriani et al. (2013) and Darby and
Prasad (2016), although one has to mention here that the
right temporal/occipital cortex had already been affected by
atrophy (and hypometabolism) in this patient at the beginning
in correspondence with Halligan’s and David’s (2001) framework.
Moreover, the extent of the identified new brain regions
associated with the Capgras delusion is also influenced by the
chosen statistical threshold as the ROI analyses rather show a
stepwise decline in GMV there.
The results of our transition analysis from the third to
the fourth follow-up, which identified the posterior cingulate
gyrus/precuneus and the right middle frontal gyrus/frontal eye
field as relevant for Capgras delusion, are also in agreement
with a recent study by Darby et al. (2017). The authors
applied lesion network mapping to identify common hubs
in the connectome related to Capgras and other delusional
misidentification syndromes in stroke patients. Brain lesions
were functionally connected to the retrosplenial cortex (as well
as posterior cingulate gyrus/precuneus, see their Figure 3), a
region most activated in functional MRI studies of familiarity,
and to the right frontal cortex, in particular the ventral frontal
cortex/anterior insula, regions most activated in functional MRI
studies of expectation violation, a component of belief evaluation.
The authors suggest that impaired familiarity perception and
belief evaluation might lead to delusional misidentifications.
As our patient study identified the same regions, one might
hypothesize analog mechanisms here. Note that the transition
analysis from the third to the fourth follow-up additionally
indicated atrophy in the right insula in our patient as illustrated
in Supplementary Video S3.
One might object that severe visuo-perceptual deficits
including prosopagnosia (the latter confirmed during first
follow-up investigation in the patient) and leading to functional
blindness might generally hamper person perception in PCA
as the disease generally impairs perception of the misidentified
object. Radicalizing this argument one even might hypothesize
that true Capgras phenomena generally cannot occur in PCA
and the syndrome’s observation is an artifact in this patient.
However, several points support our assumption that the patient
experienced a real Capgras syndrome. (i) The patient described
compensatory strategies, i.e., identifying persons by their voice
and/or gait instead of recognizing their face. Hence, person
perception was generally possible in the patient, although not
via face perception. (ii) This hypothesis is further supported
by the fact that person perception was selectively impaired
only for the spouse in our patient and even occurred only
intermittently. Although the patient had not shown any hints
for epileptic seizures until fourth follow-up, such seizures
developed 4 months thereafter. The antiepileptic drug valproate
was administered beside antipsychotics after two other seizures
(6 and 9 months after fourth follow-up). Subsequently, Capgras
delusion disappeared either due to progress of the disease (MMSE
2/30 points 8 months after fourth follow-up), antipsychotics, or
antiepileptics. (iii) The specificity of the Capgras delusion in PCA
is also supported by other case studies reporting Capgras delusion
in a patient with blindness (referred to in Cipriani et al., 2013).
Cipriani et al. (2013) conclude that intact vision seems not to
be necessary for Capgras delusion, and that also other senses
and their misinterpretation, such as hearing and touch, might
contribute to this phenomenon. However, the high prevalence of
visuoperceptual and visuospatial deficits in PCA patients might
have kept other authors from interpreting misidentifications of
relatives, etc., as Capgras phenomena.
For choline esterase inhibitors effects on functional and
structural imaging have been reported in Alzheimer’s disease
and its prestage mild cognitive impairment (Prins et al.,
2014; Kim et al., 2017). Because the patient was treated with
galantamine, we cannot rule out modulating effects on our
results, although one would expect here rather a deceleration of
atrophy/hypometabolism rates.
One might further discuss how atrophy in frontal areas can
be related to Capgras delusion in this patient as many previous
studies have shown significant atrophy in PCA patients also
in frontal areas when compared to healthy controls. Indeed,
frontal areas might be involved in PCA, but in late stages only.
Recently, Firth et al. (2019) investigated atrophy longitudinally
in PCA in a large cohort with approximately 100 patients.
Patients with PCA showed early occipitoparietal atrophy, with
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subsequent higher rates of temporal atrophy, whereas atrophy
in frontal areas appeared much later and to smaller extent.
This finding agrees with results in our patient showing late and
regionally restricted frontal atrophy. Still, the question remains
why atrophy in the (frontal) brain regions might lead to Capgras
delusion in this single patient but not in other patients with PCA.
Here one has to state that it is methodologically problematic to
compare group studies with single case studies. Group studies
conduct group statistics across numerous subjects, accordingly
statistical power is large, clusters/effects are large. But one cannot
conclude anything about single subjects. Moreover, individual
clinical deficits are not taken into account beside individual
atrophy patterns. One might conclude that group data and single
subject analyses are in principle not comparable. Our patient
supports evidence—in a lesion model based on longitudinal
single-subject VBM analysis—that PCA affects specific structural
and functional neural networks leading to Capgras delusion.
PATIENT’S PERSPECTIVE
Due to the severity of impairment the patient could not comment
herself. The spouse reported that he was surprised and terrified of
the speed of the deficits’ development.
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